CNS Pharmaceuticals CNSP 深 沪
等待开盘 05-11 09:30:00 美东时间
7.39
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 7.39
- 总市值 29.58万
- 52周最高 10.588
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.7303
- 委 比 0.00%
- 总股本 4.00万
- 历史最高 10.588
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.066
- 每 手 1
- 风险率 2.85%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Gold Falls Over 2%; US Factory Orders Rise In March
US stocks traded lower with Dow down 0.4%. NASDAQ up 0.07% while S&P 500 fell 0.03%. Norwegian Cruise Line beat Q1 estimates but cut FY2026 guidance.
05-05 00:05
Dow Falls Over 150 Points; Tyson Foods Posts Upbeat Earnings
US stocks fell, Dow dropped 150 points. Dow at 49,321.96, NASDAQ at 25,109.76, S&P 500 at 7,223.30. Tyson Foods beat earnings, stock up. Energy and Xanadu Quantum down.
05-04 21:40
Nano-Cap CNS Pharmaceuticals Stock Explodes As Capital Raise Fuels Pivot
CNS Pharmaceuticals announces $22.5 million financing as the company pivots its strategy, eyes asset acquisitions.
05-04 21:24
Market-Moving News for May 4th
EBAY: 13% | GameStop's Cohen Threatens Proxy War In High-Stakes eBay Bid CNSP: 165% | CNS Pharmaceuticals Announces Oversubscribed $22.5 Million Private Placement Financing ORGN: -46% | Origin
05-04 19:12
CNS Pharmaceuticals Appoints Steve O'Loughlin CFO, Effective March 2, Succeeding Christopher Downs
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001729427/000168316826001066/cns_8k.htm
02-17 21:42
CNS Pharmaceuticals Appoints Rami Levin CEO, Succeeding John Climaco
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous
2025-12-17 21:53
CNS Pharmaceuticals Q3 EPS $(5.76) Beats $(7.09) Estimate
CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(5.76) per share which beat the analyst consensus estimate of $(7.09) by 18.82 percent. This is a 96.24 percent increase over losses of $(153.20) per share
2025-11-17 22:43
